FDA Approved Biologics and Pending Applications
elotuzumab
BL 761035
belatacept
BL 125288
nivolumab
BL 125554 [BL 125527]
abatacept
BL 125118
ipilimumab
BL 125377
U.S. Patent Litigations
ERBITUX2:13-cv-05400 (N.D. Cal.)2:15-cv-06133 (E.D. Pa.)3:13-cv-02045 (N.D. Cal.)ERBITUX / GENENTECH CABILLY / YERVOY2:13-cv-05400 (N.D. Cal.)3:13-cv-02045 (N.D. Cal.)OPDIVO / BAVENCIO1:17-cv-01029 (D. Del.)OPDIVO / IMFINZI1:17-cv-01028 (D. Del.)OPDIVO / KEYTRUDA1:14-cv-01131 (D. Del.)1:15-cv-00560 (D. Del.)1:15-cv-00572 (D. Del.)OPDIVO / TECENTRIQ1:17-cv-01027 (D. Del.)